SC 13G Filing

Company

Alaunos Therapeutics, Inc.

Filed

February 10, 2006

Accession Number

0000950116-06-000485

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →